Effect of Organic Naked Oat With Whole Germ on Type 2 Diabetes Mellitus
2 other identifiers
interventional
445
1 country
1
Brief Summary
Dietary modification is of great essential for the prevention and treatment of type 2 diabetes mellitus. Common oat (Avena sativa L.) and its products showed a great potential benefits on NCDs including type 2 diabetes mellitus. But data about such effects of naked oat (Avena nuda L.) is still unavailable. The investigators aimed to examine the effects of organic naked oat with whole germ (ONOG) plus diet on patients with type 2 diabetes. After a pre-study with healthy adults, a randomized, single-blinded, multi-arm parallel trial of 30 days would be carried out in adults of 50-65 years old with type 2 diabetes. Participants would be randomly assigned to one of the four following groups: usual care group (only basic health advice, no other interventions), diet group (systematic education, structured dietary), 50g-ONOG plus diet group (all the interventions of diet group plus replacement of 50g ONOG per day) and 100g-ONOG plus diet group. A regular follow-up for years would be carried out to predict the long-term effects of ONOG plus diet intervention on patients with type 2 diabetes. The investigators hypothesized that ONOG combined with diet would have better effects on glycaemia and insulin resistance control in addition to those yielded by diet or usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 9, 2011
CompletedFirst Posted
Study publicly available on registry
December 19, 2011
CompletedDecember 19, 2011
December 1, 2011
3 months
December 9, 2011
December 15, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
change from baseline in Hb1Ac concentration Hematology index detection Hematology index detection Hematology index detection Hematology index detection Hematology index detection
Venous blood samples were collected for determination of glycosylated haemoglobin (HbA1c).Changes in outcomes were calculated as values at the end of the intervention period minus those of baseline.
baseline, 30 days, 6 months and 1 year
changes from baseline in insulin resistance Hematology index detection Hematology index detection Hematology index detection Hematology index detection Hematology index detection
Venous blood samples were collected for determination of serum insulin.Insulin resistance was measured by HOMO-IR, calculated with the following formula: HOMO-IR=Fasting serum insulin(μU/mL)\*FPG(mmol/L)/22.5
baseline, 30 days, 6 months and 1 year
Secondary Outcomes (5)
changs from baseline in plasma glucose
baseline, 30 days, 6 months and 1 year
changes from baseline in lipid profile
baseline, 30 days, 6 months and 1 year
changes from baseline in BMI
baseline, 30 days, 6 months and 1 year
changes from baseline in plasma levels of total glutathione peroxidase, malondialdehyde(MDA), superoxide dismutase (SOD), IL-6 and TNF-а
baseline and 30 days
changes from baseline in WHR
baseline, 30 days, 6 months and 1 year
Study Arms (4)
Usual care group
NO INTERVENTIONThe usual care group was used as control group and didn't receive any intervention except standard health advice at the beginning and the end of the study.
diet group
NO INTERVENTIONThis group received systematic education about nutrition and diabetes combined with a structured dietary intervention.
50g-ONOG plus diet group
EXPERIMENTALThis group received systematic education about nutrition and diabetes combined with a structured dietary intervention. Participants in the 50g-ONOG plus diet groups were asked to replace their customarily used staple food with oat porridge containing 50g ONOG.
100g-ONOG plus diet group
EXPERIMENTALThis group received systematic education about nutrition and diabetes combined with a structured dietary intervention. Participants in the 100g-ONOG plus diet groups were asked to replace their customarily used staple food with oat porridge containing 100g ONOG.
Interventions
The experimental product was ONOG (Inner Mongolia Sanzhuliang Natural Oats Industry Corporation), which was produced in the northwest part of China, applying with the organic standards. Participants in the 50g and 100g-ONOG plus diet groups were asked to replace their customarily used staple food with oat porridge containing 50g or 100g ONOG.
Eligibility Criteria
You may qualify if:
- all adults aged 50-65 years old with Type 2 Diabetes Mellitus
- stable physical condition
- fasting plasma glucose (FPG) concentration ≥7.8mmol/L or 2-h postprandial blood glucose (PG) ≥11.1mmol/L after 75g oral dextrose with an glycated hemoglobin (HbA1c)\>7 %, stable medication.
You may not qualify if:
- pregnancy
- breastfeeding
- severe renal or hepatic complications
- treatment by glucocorticoid
- having pancreatic disease or malignancy in recent 3 months
- other factors that may limit adherence to interventions or affect conduct of the trial or participation in another supplementary feeding programme.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yong Lilead
Study Sites (1)
Arms Industry New Century Hotel
Baotou, Inner Mongolia, 014032, China
Related Publications (3)
Li X, Cai X, Ma X, Jing L, Gu J, Bao L, Li J, Xu M, Zhang Z, Li Y. Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial. Nutrients. 2016 Sep 7;8(9):549. doi: 10.3390/nu8090549.
PMID: 27618090DERIVEDGu J, Jing L, Ma X, Zhang Z, Xu M, Wang J, Li Y. Naked oat combined with a structured dietary intervention affects oxidative stress but not inflammation in diabetic dyslipidemia. Nutr Metab Cardiovasc Dis. 2014 Dec;24(12):e35-7. doi: 10.1016/j.numecd.2014.08.009. Epub 2014 Sep 16. No abstract available.
PMID: 25315670DERIVEDMa X, Gu J, Zhang Z, Jing L, Xu M, Dai X, Jiang Y, Li Y, Bao L, Cai X, Ding Y, Wang J, Li Y, Li Y. Effects of Avena nuda L. on metabolic control and cardiovascular disease risk among Chinese patients with diabetes and meeting metabolic syndrome criteria: secondary analysis of a randomized clinical trial. Eur J Clin Nutr. 2013 Dec;67(12):1291-7. doi: 10.1038/ejcn.2013.201. Epub 2013 Oct 16.
PMID: 24129363DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 9, 2011
First Posted
December 19, 2011
Study Start
August 1, 2011
Primary Completion
November 1, 2011
Last Updated
December 19, 2011
Record last verified: 2011-12